Sartorius Stedim Biotech Aktie
189,20
EUR
+0,05
EUR
+0,03
%
190,15
EUR
+0,15
EUR
+0,08
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
10.10.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
08.07.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
06.06.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
16.04.25 | Sartorius Stedim Biotech Market-Perform | Bernstein Research | |
29.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
24.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
22.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
Werbung
|
|||
27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group |
Werbung
Werbung